We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gut Microbe Strains Linked to More Severe Strokes

By LabMedica International staff writers
Posted on 09 May 2022

The human microbiome is composed of bacteria, archaea, viruses and eukaryotic microbes that reside in and on individual bodies. More...

These microbes have tremendous potential to impact that physiology, both in health and in disease.

Globally, about 13 million people experience a stroke each year and about 5.5 million people die from strokes. A stroke happens when blood is not able to reach the brain. If blood flow to the brain becomes blocked, oxygen and vital nutrients cannot get to the brain, which can cause brain cells to die.

Medical Scientists at the Sant Pau Research Institute (Barcelona, Spain) and their colleagues have linked specific bacteria in the gut microbiome to both stroke severity and recovery. The team analyzed studied samples from 89 ischemic stroke patients and 12 controls. They performed shotgun metagenomics sequencing to analyze the taxonomic profiles.

The scientists identified multiple types of bacteria associated with an increased risk for ischemic stroke, including the bacteria Fusobacterium and Lactobacillus. They also found the bacteria Negativibacillus and Lentisphaeria were associated with a more severe stroke in the acute phase and the bacteria Acidaminococcus led to poor post-stroke recovery after three months.

Miquel Lledós, PhD, the lead author of the study, said, “Acidaminococcus is an opportunistic pathogen, and this genus has already been related to a higher risk of stroke.” Acidaminococcus is a member of the family Veillonellaceae, known for producing succinate, a compound linked to increased risk factors for cardiovascular disease.”

Dr. Lledós added, “In other pathologies, clinical trials are being carried out in which scientists replace the intestinal flora through dietary changes or fecal transplantation from healthy individuals that is much more consistent in the long term. One way to do that is by using lyophilized compounds of microorganisms in capsules that are easy to ingest and that modify the intestinal flora.”

The authors concluded that multiple new taxonomic profiles associated with stroke, revealing that gut microbiome could be an important factor associated with stroke risk and stroke acute and long-term outcome. The study was presented at the 2022 European Stroke Organisation Conference held May 4-6, 2022 in Lyon, France.

Related Links:
Sant Pau Research Institute 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings support integrating high-performing plasma p-tau217 assays into Alzheimer’s diagnostic workflows, provided that platform-specific calibration and standardized testing protocols are in place. (Image Credit: Adobe Stock)

Head-to-Head Study Compares Blood Tests for Early Alzheimer’s Disease Detection

Accurate, scalable diagnostics are becoming increasingly important as disease-modifying therapies reshape Alzheimer’s disease care, yet many patients still rely on invasive cerebrospinal fluid sampling... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.